findmyKOL
Clinical trialNCT00132691CompletedPhase 4Interventional

Multicenter Uveitis Steroid Treatment (MUST) Trial

SponsorJHSPH Center for Clinical TrialsEnrollment255Uveitis
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to compare the effectiveness of standardized systemic therapy versus fluocinolone acetonide implant therapy for the treatment of severe cases of non-infectious intermediate uveitis, posterior uveitis, or panuveitis.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia
  • Royal Victoria Eye & Ear Hospital

    East Melbourne, Australia

United Kingdom
  • United Kingdom Institute of Ophthalmology

    London, United Kingdom

United States
  • Jacobs Retina Center, Ucsd

    La Jolla, California, United States

  • Doheny Eye Institute, Usc

    Los Angeles, California, United States

  • Jules Stein Eye Institute, Ucla

    Los Angeles, California, United States

  • Proctor Foundation, Ucsf

    San Francisco, California, United States

  • Anne Bates Leach Eye Hospital, University of Miami Miller School of Medicine

    Miami, Florida, United States

  • University of South Florida

    Tampa, Florida, United States

  • Emory University

    Atlanta, Georgia, United States

  • Rush University Medical Center

    Chicago, Illinois, United States

  • University of Illinois at Chicago Eye Center

    Chicago, Illinois, United States

  • Wilmer Eye Institute, Johns Hopkins University

    Baltimore, Maryland, United States

  • National Eye Institute, Nih

    Bethesda, Maryland, United States

  • Massachusetts Eye Research & Surgery Institute

    Cambridge, Massachusetts, United States

  • Kellogg Eye Center, University of Michigan

    Ann Arbor, Michigan, United States

  • Barnes Retina Institute

    St Louis, Missouri, United States

  • New York Eye and Ear Infirmary

    New York, New York, United States

  • Duke Eye Center, Duke University

    Durham, North Carolina, United States

  • Scheie Eye Institute, University of Pennsylvania

    Philadelphia, Pennsylvania, United States

  • Texas Retina Associates

    Dallas, Texas, United States

  • Vitreoretinal Consultants

    Houston, Texas, United States

  • John A. Moran Eye Center, University of Utah

    Salt Lake City, Utah, United States

  • Virginia Eye Consultants

    Norfolk, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Fluocinolone acetonide intraocular implantOral corticosteroid with immunosuppressive agents as needed
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Sept 2005
Primary completion
31 Dec 2010
Completion
31 Dec 2010
Last update posted
25 Nov 2016
Registered enrollment
255
Registry id
NCT00132691

Cross-registrations

ISRCTN (UK)ISRCTN15396562

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.